% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. Message Board

  • tonytiger706 tonytiger706 Aug 20, 2014 8:26 AM Flag

    Any idea when the secondary will be filled

    so snta can fill the coffers and move forward with fda approval of ganetespib? Any known time frame for a NDA review? I me!

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • What do you think they are doing with these open At-The-Money Offerings???

      All of the clinical information can be found on the website. There is an August 2014 corporate presentation link on their landing page. By year end, I believe Synta will have new messaging and branding to support ganetespib by virtue of them retaining the Navicor Group in April.

      My guess is the Company will have somewhere around $120 million on the balance sheet by the time we get to the next quarterly call (in November), providing them a runway into 1H2016 (which can obviously be extended should they sign a distribution deal taking a chunk of the cash upfront).

      Oh, and yes, don't be lazy. It's your money...get on it.

      Sentiment: Buy

0.3430.000(0.00%)Jul 22 3:59 PMEDT